Mumbai headquartered Glenmark pharmaceuticals has annpunced that the US affiliate of the company Glenmark Generics has got final sanction from US Food and Drug Administration (USFDA) to sell Ranitidine Hydrochloride on prescription basis.

The approval has been granted for 150 mg and 300 mg dosage of the drug.

According to the sources, Ranitidine is indicated for prevention and developing of ulcer in the stomach. The drug also reduces stomach pain, diarrhea, and loss of appetite that ulcers can cause.